RedHill Biopharma Fundamental Relationships

RDHL -- Israel Stock  

ILS 325.80  14.60  4.69%

The Drivers Module shows relationships between RedHill Biopharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of RedHill Biopharma Ltd over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center.

RedHill Biopharma Cash Flow from Operations vs. Return On Equity Fundamental Analysis

RedHill Biopharma Ltd is rated second in return on equity category among related companies. It is rated second in cash flow from operations category among related companies .
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how effecently a company utilizes investments to generate income.
RedHill Biopharma 
Return on Equity 
 = 
Net Income 
Total Equity 
X
100 
=
(80.66)%
For most industries Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
RedHill Biopharma 
Operating Cash Flow 
 = 
EBITDA 
-  
Taxes 
=
(34.46M)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.

RedHill Biopharma Cash Flow from Operations Comparison

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Search macroaxis.com